AMENDMENT TO RFA-DK-02-028:  GEORGE M. O'BRIEN KIDNEY RESEARCH CENTERS

Release Date:  January 2, 2002

NOTICE:  NOT-DK-02-001

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
 (http://www.niddk.nih.gov/)

The purpose of this Notice is to clarify a statement that was included 
within the ELIGIBILITY REQUIREMENTS section of RFA DK-02-028.  The 
statement  "Support will not be provided for applications with research 
activities focused exclusively on basic research, or clinical research 
or trials, or epidemiological research" should be replaced with the 
following statement:  "Support will not be provided for applications 
with research activities focused exclusively on clinical research or 
trials, or epidemiological research."

All other aspects of the RFA remain unchanged.  

The full text of the RFA, which was published on October 1, 2001, can 
be accessed at the following location: 
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-02-028.html.

INQUIRIES

Inquiries may be directed to:

Lawrence Agodoa, M.D.
Director, End-Stage Renal Disease Program
Division of  Kidney, Urologic, and Hematologic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health 
2 Democracy, Room 653
6707 Democracy Boulevard
Bethesda, Maryland  20892-5454
Telephone:  (301) 594-9652
FAX:  (301) 594-9358
E-mail:  la21j@nih.gov

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.